Milestone Book Value Per Share from 2010 to 2024

MIST Stock

USD 1.85 0.01 0.54%

Milestone Pharmaceuticals Book Value Per Share yearly trend continues to be comparatively stable with very little volatility. Book Value Per Share will likely drop to 0.37 in 2024. Book Value Per Share is the ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of Milestone Pharmaceuticals according to its financial statements. View All Fundamentals

Book Value Per Share

First Reported

2010-12-31

Previous Quarter

0.39042477

Current Value

0.37

Quarterly Volatility

2.76492918

Credit Downgrade

Yuan Drop

Covid

Check Milestone Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Milestone Pharmaceuticals' main balance sheet or income statement drivers, such as Tax Provision of 0.0, Net Interest Income of 1.2 M or Interest Income of 3.7 M, as well as many indicators such as Price To Sales Ratio of 75.32, Dividend Yield of 0.0 or PTB Ratio of 4.49. Milestone financial statements analysis is a perfect complement when working with Milestone Pharmaceuticals Valuation or Volatility modules.

Check out the analysis of Milestone Pharmaceuticals Correlation against competitors.

For more information on how to buy Milestone Stock please use our How to Invest in Milestone Pharmaceuticals guide.

Latest Milestone Pharmaceuticals' Book Value Per Share Growth Pattern

Below is the plot of the Book Value Per Share of Milestone Pharmaceuticals over the last few years. It is the ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements. Milestone Pharmaceuticals' Book Value Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Milestone Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 0.39 X

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Book Value Per Share

Timeline

Milestone Book Value Per Share Regression Statistics

	Arithmetic Mean	0.24
	Coefficient Of Variation	1,141
	Mean Deviation	2.10
	Median	(1.40)
	Standard Deviation	2.76
	Sample Variance	7.64
	Range	9.615
	R-Value	0.52
	Mean Square Error	6.03
	R-Squared	0.27
	Significance	0.05
	Slope	0.32
	Total Sum of Squares	107.03

Milestone Book Value Per Share History

	2024	0.37
	2023	0.39
	2022	1.56
	2021	2.69
	2020	4.88
	2019	7.28
	2018	-2.33

Other Fundumenentals of Milestone Pharmaceuticals

Tangible Book Value Per Share

Milestone Pharmaceuticals Book Value Per Share component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Short Term Investments	Capital Surpluse	Total Liab	Net Invested Capital	Total Current Assets	Net Working Capital	Common Stock	Property Plant Equipment	Capital Stock
Total Assets		0.86	0.88	-0.56	-0.63	0.96	0.33	0.57	0.58	-0.48	0.89	1.0	1.0	0.83	0.49	0.83
Total Stockholder Equity	0.86		0.96	-0.54	-0.57	0.84	0.14	0.68	0.53	-0.82	0.97	0.86	0.86	0.88	0.42	0.86
Net Tangible Assets	0.88	0.96		-0.36	-0.74	0.91	0.4	0.73	0.7	-0.79	1.0	0.88	0.87	0.95	0.61	0.95
Net Debt	-0.56	-0.54	-0.36		-0.18	-0.45	0.52	-0.03	0.19	0.16	-0.38	-0.57	-0.58	-0.21	0.39	-0.18
Retained Earnings	-0.63	-0.57	-0.74	-0.18		-0.74	-0.82	-0.54	-0.98	0.48	-0.73	-0.62	-0.6	-0.88	-0.93	-0.9
Accounts Payable	0.96	0.84	0.91	-0.45	-0.74		0.48	0.59	0.68	-0.48	0.91	0.96	0.95	0.88	0.59	0.89
Net Receivables	0.33	0.14	0.4	0.52	-0.82	0.48		0.41	0.77	-0.13	0.38	0.32	0.3	0.53	0.88	0.57
Short Term Investments	0.57	0.68	0.73	-0.03	-0.54	0.59	0.41		0.39	-0.62	0.73	0.56	0.55	0.72	0.67	0.71
Capital Surpluse	0.58	0.53	0.7	0.19	-0.98	0.68	0.77	0.39		-0.48	0.69	0.57	0.55	0.84	0.87	0.86
Total Liab	-0.48	-0.82	-0.79	0.16	0.48	-0.48	-0.13	-0.62	-0.48		-0.8	-0.48	-0.47	-0.71	-0.4	-0.71
Net Invested Capital	0.89	0.97	1.0	-0.38	-0.73	0.91	0.38	0.73	0.69	-0.8		0.88	0.88	0.95	0.6	0.94
Total Current Assets	1.0	0.86	0.88	-0.57	-0.62	0.96	0.32	0.56	0.57	-0.48	0.88		1.0	0.82	0.47	0.82
Net Working Capital	1.0	0.86	0.87	-0.58	-0.6	0.95	0.3	0.55	0.55	-0.47	0.88	1.0		0.8	0.46	0.81
Common Stock	0.83	0.88	0.95	-0.21	-0.88	0.88	0.53	0.72	0.84	-0.71	0.95	0.82	0.8		0.77	1.0
Property Plant Equipment	0.49	0.42	0.61	0.39	-0.93	0.59	0.88	0.67	0.87	-0.4	0.6	0.47	0.46	0.77		0.79
Capital Stock	0.83	0.86	0.95	-0.18	-0.9	0.89	0.57	0.71	0.86	-0.71	0.94	0.82	0.81	1.0	0.79

Click cells to compare fundamentals

About Milestone Pharmaceuticals Financial Statements

Milestone Pharmaceuticals shareholders use historical fundamental indicators, such as Book Value Per Share, to determine how well the company is positioned to perform in the future. Although Milestone Pharmaceuticals investors may analyze each financial statement separately, they are all interrelated. The changes in Milestone Pharmaceuticals' assets and liabilities, for example, are also reflected in the revenues and expenses on on Milestone Pharmaceuticals' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

	Last Reported	Projected for Next Year
Book Value Per Share	0.39	0.37
Tangible Book Value Per Share	0.39	0.37

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Milestone Stock Analysis

When running Milestone Pharmaceuticals' price analysis, check to measure Milestone Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Milestone Pharmaceuticals is operating at the current time. Most of Milestone Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Milestone Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Milestone Pharmaceuticals' price. Additionally, you may evaluate how the addition of Milestone Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC